WHO ICTRP trial

AZATHIOPRINE IN TYPE 1 LEPROSY REACTIONS-THE LEPROSY MISSION TRUST INDIA

CTRI/2016/12/007558 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2016/12/007558
Public title AZATHIOPRINE IN TYPE 1 LEPROSY REACTIONS-THE LEPROSY MISSION TRUST INDIA
Scientific title AZATHIOPRINE IN TYPE 1 LEPROSY REACTIONS
Primary sponsor The Leprosy Mission Trust India
Secondary sponsors The Leprosy Mission Trust India
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: null- Leprosy Patients with Type 1 Reaction and neuritis
Interventions Intervention1: Azathioprine, prednisolone: 1 2 3 4 5 6 7 8 9 10 11 12 Wk 4 Wk 8 Wk 12 Wk 16 Wk 20 Wk 24 Wk 28 Wk 32 Wk 36 Wk 40 Wk 44 Wk 48 Arm 1 Prednisolone Placebo Arm 2 Prednisolone Azathioprine Placebo Arm 3 Prednisolone Azathioprine…
Registration date Sep 12, 2016
Target size 345
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations